Pluristem slumps as FDA suspends stem cell study
June 5, 2013
Pluristem Therapeutics Inc. said Tuesday the Food and Drug Administration suspended a clinical trial of one of its stem cell therapies, sending the company’s shares lower. (Businessweek)
June 5, 2013
Pluristem Therapeutics Inc. said Tuesday the Food and Drug Administration suspended a clinical trial of one of its stem cell therapies, sending the company’s shares lower. (Businessweek)